Rocket Pharmaceuticals Inc (RCKT)
11.79
-0.76
(-6.06%)
USD |
NASDAQ |
Jan 08, 16:00
11.78
-0.01
(-0.08%)
After-Hours: 20:00
Rocket Pharmaceuticals Research and Development Expense (Annual): 186.34M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Emergent BioSolutions Inc | 111.40M |
| Inogen Inc | 20.84M |
| Marinus Pharmaceuticals Inc | 99.39M |
| Spyre Therapeutics Inc | 89.50M |
| NovaBay Pharmaceuticals Inc | 0.068M |